AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25416084 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative impact on life due to weight vs diabetes
Number of subjects: 1820
Study 25416084 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling unsatisfied with weight loss ability
Number of subjects: 1820
Study 22205196 — intervention group
Group type: EXPERIMENTAL
Intervention: NLMEM-based analysis of somatropin
Number of subjects: 0
Study 22205196 — intervention group
Group type: EXPERIMENTAL
Intervention: NLMEM-based analysis of epoetin-α
Number of subjects: 0
Study 22205196 — intervention group
Group type: COMPARATOR
Intervention: Noncompartmental analysis (NCA)
Number of subjects: 0
Study 22205196 — intervention group
Group type: EXPERIMENTAL
Intervention: NLMEM
Number of subjects: 0
Study 19204860 — intervention group
Group type: EXPERIMENTAL
Intervention: High organizational assistance
Number of subjects: 296
Study 19204860 — intervention group
Group type: COMPARATOR
Intervention: Low organizational assistance
Number of subjects: 296
Study 19204860 — intervention group
Group type: EXPERIMENTAL
Intervention: High severity of smoke-free policy
Number of subjects: 296
Study 19204860 — intervention group
Group type: COMPARATOR
Intervention: Low severity of smoke-free policy
Number of subjects: 296
Study 17710152 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV vaccination in infancy
Number of subjects: 492
Study 17710152 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose of HBV vaccine
Number of subjects: 492
Study 17710152 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated control group
Number of subjects: 492
Study 15567983 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei supplementation (750 mg daily containing 16 billion bacteria)
Number of subjects: 70
Study 15567983 — intervention group
Group type: COMPARATOR
Intervention: Standard quadruple therapy without Lactobacillus casei supplementation
Number of subjects: 70
Study 12020142 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate, 10 mg/d
Number of subjects: 327
Study 12020142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study 9609268 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg misoprostol
Number of subjects: 0
Study 9609268 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg misoprostol
Number of subjects: 0
Study 9609268 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 7709043 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal pulmonary rehabilitation program
Number of subjects: 30
Study 7709043 — intervention group
Group type: COMPARATOR
Intervention: No formal pulmonary rehabilitation
Number of subjects: 30
Study 2693683 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% metronidazole gel
Number of subjects: 10
Study 2693683 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 10
Study 856386 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature chart interpretation by gynaecologists (experts)
Number of subjects: 60
Study 856386 — intervention group
Group type: COMPARATOR
Intervention: Temperature chart interpretation by non-experts (control group)
Number of subjects: 60
Study 856386 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature chart interpretation (both groups)
Number of subjects: 60
Study 856386 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature charts from normal subjects
Number of subjects: 60
Study 856386 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature charts from infertile patients
Number of subjects: 60
Study 30452705 — intervention group
Group type: EXPERIMENTAL
Intervention: Active condition (n = 63)
Number of subjects: 127
Study 30452705 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 64)
Number of subjects: 127
Study 31778431 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscosupplementation (VS, n=16)
Number of subjects: 44
Study 31778431 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscosupplementation plus dexamethasone (VD, n=16)
Number of subjects: 44
Study 31778431 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DX, n=12)
Number of subjects: 44
Study 28351393 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey supplementation (20 g/day for 12 weeks)
Number of subjects: 64
Study 28351393 — intervention group
Group type: COMPARATOR
Intervention: Control group (smokers without honey)
Number of subjects: 64
Study 26016871 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Tests (RDTs)
Number of subjects: 646
Study 26016871 — intervention group
Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 646
Study 26016871 — intervention group
Group type: COMPARATOR
Intervention: Clinical Diagnosis
Number of subjects: 646
Study 24365449 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin (550 mg, twice daily)
Number of subjects: 392
Study 22034767 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative treatment
Number of subjects: 0
Study 22034767 — intervention group
Group type: COMPARATOR
Intervention: Other advocated therapies
Number of subjects: 0
Study 20441066 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (Incredible Years Teacher Training Programme + social and emotional skills lessons)
Number of subjects: 135
Study 20441066 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 135
Study 16869815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) 10 mg
Number of subjects: 42
Study 16869815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) 20 mg
Number of subjects: 42
Study 16869815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) 40 mg
Number of subjects: 42
Study 16869815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) multiple doses
Number of subjects: 42
Study 16869815 — intervention group
Group type: COMPARATOR
Intervention: Food effect on Adefovir dipivoxil (ADV)
Number of subjects: 42
Study 15258862 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid-absorbing gut suture (RG)
Number of subjects: 145
Study 15258862 — intervention group
Group type: EXPERIMENTAL
Intervention: Octylcyanoacrylate (OC)
Number of subjects: 145
Study 15258862 — intervention group
Group type: COMPARATOR
Intervention: Nylon suture (NL)
Number of subjects: 145
Study 11720199 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microg ethinyl estradiol
Number of subjects: 46
Study 11720199 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg ethinyl estradiol
Number of subjects: 46
Study 11720199 — intervention group
Group type: EXPERIMENTAL
Intervention: Both OCs
Number of subjects: 46
Study 11720199 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction from 30 microg to 20 microg ethinyl estradiol
Number of subjects: 46
Study 9452157 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate therapy (intravenous infusion or orally)
Number of subjects: 966
Study 8259188 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 million units of recombinant interferon alfa-2a (three times a week for 48 weeks)
Number of subjects: 42
Study 8259188 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant interferon alfa-2a (three times a week for 48 weeks)
Number of subjects: 42
Study 8259188 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 42
Study 8259188 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 million units of recombinant interferon alfa-2a
Number of subjects: 42
Study 8259188 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant interferon alfa-2a
Number of subjects: 42
Study 3111690 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide 5‐mononitrate (IS 5‐MN) given orally
Number of subjects: 10
Study 3111690 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 10
Study 30292451 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 68
Study 30292451 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 68
Study 27737686 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention emphasizing COPD management
Number of subjects: 0
Study 27737686 — intervention group
Group type: COMPARATOR
Intervention: Usual care and a COPD education pamphlet (Control)
Number of subjects: 0
Study 27737686 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 0
Study 25136050 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV4 vaccine
Number of subjects: 1781
Study 25136050 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 1781
Study 22894624 — intervention group
Group type: EXPERIMENTAL
Intervention: AMR101 4 g/day
Number of subjects: 229
Study 22894624 — intervention group
Group type: EXPERIMENTAL
Intervention: AMR101 2 g/day
Number of subjects: 229
Study 22894624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study 19821184 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy (for subgroup of n=101)
Number of subjects: 416
Study 19821184 — intervention group
Group type: COMPARATOR
Intervention: All patients seeking treatment (n=416)
Number of subjects: 416
Study 17209220 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin supplements
Number of subjects: 0
Study 17209220 — intervention group
Group type: COMPARATOR
Intervention: Multivitamins
Number of subjects: 0
Study 17209220 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin and multivitamin-mineral supplements
Number of subjects: 0
Study 17209220 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study 15902439 — intervention group
Group type: EXPERIMENTAL
Intervention: p-[(123)I]iodo-L-phenylalanine (IPA) SPECT
Number of subjects: 45
Study 12054161 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/day of pamidronate
Number of subjects: 101
Study 12054161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 10080463 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 395
Study 10080463 — intervention group
Group type: COMPARATOR
Intervention: t-PA
Number of subjects: 395
Study 7744191 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol 10 mg
Number of subjects: 487
Study 7744191 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambuterol 20 mg
Number of subjects: 487
Study 7744191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study 1539551 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural head position (NHP)
Number of subjects: 52
Study 3516296 — intervention group
Group type: EXPERIMENTAL
Intervention: Terodiline 25 mg bid
Number of subjects: 18
Study 29685325 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia patients under stress conditions (no stress, noise, social stress)
Number of subjects: 120
Study 29685325 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia patients
Number of subjects: 120
Study 29685325 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia patients under stress conditions
Number of subjects: 120
Study 29685325 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management programs
Number of subjects: 120
Study 29685325 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions to reduce overconfidence in social cognition judgments
Number of subjects: 120
Study 27472521 — intervention group
Group type: EXPERIMENTAL
Intervention: Biobehavioral intervention
Number of subjects: 435
Study 27472521 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care intervention
Number of subjects: 435
Study 27472521 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 435
Study 27472521 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (biobehavioral, self-care, no intervention)
Number of subjects: 435
Study 25472936 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-bonded covered stents (VIABAHN® Endoprosthesis)
Number of subjects: 141
Study 25472936 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 141
Study 22829211 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger-motivated rape scenario
Number of subjects: 134
Study 22829211 — intervention group
Group type: EXPERIMENTAL
Intervention: Rape
Number of subjects: 134
Study 22042106 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine
Number of subjects: 33
Study 22042106 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study 22042106 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 33
Study 18450596 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 LCPUFA (350 mg DHA and 650 mg EPA)
Number of subjects: 40
Study 18450596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 18473976 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AI)
Number of subjects: 0
Study 18473976 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study 14594184 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided to self-hypnotic relaxation
Number of subjects: 146
Study 14594184 — intervention group
Group type: COMPARATOR
Intervention: Structured empathic attention
Number of subjects: 146
Study 10949784 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of randomized, controlled trials of cancer therapy
Number of subjects: 0
Study 10949784 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis
Number of subjects: 0
Study 10949784 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of individual patient data
Number of subjects: 0
Study 7762523 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (46% of total energy)
Number of subjects: 105
Study 7762523 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (24% of total energy)
Number of subjects: 105
Study 2212299 — intervention group
Group type: COMPARATOR
Intervention: Loudness growth in 1/2-octave bands (LGOB) method using noise bands centered at 0.25, 0.5, 1.0, 2.0, and 4.0 kHz; subjective levels between threshold of hearing and 'too loud' level.
Number of subjects: 0
Study 6102739 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-mercaptopurine (6-MP)
Number of subjects: 83
Study 6102739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 31729964 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil in the observational group for patients with pathologic complete response or yp stage I
Number of subjects: 0
Study 31729964 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin combined with 5-fluorouracil
Number of subjects: 0
Study 31729964 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil alone
Number of subjects: 0
Study 28880899 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate sedation (Ce at 50% of Ce-LOR)
Number of subjects: 16
Study 28880899 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sedation (Ce at 75% of Ce-LOR)
Number of subjects: 16
Study 28880899 — intervention group
Group type: COMPARATOR
Intervention: Awake control state
Number of subjects: 16
Study 25970149 — intervention group
Group type: EXPERIMENTAL
Intervention: One egg per day
Number of subjects: 29
Study 25970149 — intervention group
Group type: COMPARATOR
Intervention: Oatmeal-based breakfast
Number of subjects: 29
Study 23439424 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate Reserve (HRR)
Number of subjects: 30
Study 23439424 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic Equation for Treadmill Walking (METW)
Number of subjects: 30
Study 23439424 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Heart Rate (DIRECT HR)
Number of subjects: 30
Study 23439424 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate of Perceived Exertion (RPE)
Number of subjects: 30
Study 23439424 — intervention group
Group type: EXPERIMENTAL
Intervention: HRR, METW, DIRECT HR
Number of subjects: 30
Study 21733143 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice
Number of subjects: 358
Study 21733143 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplement
Number of subjects: 358
Study 21733143 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice plus supplement
Number of subjects: 358
Study 21733143 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 358
Study 21733143 — intervention group
Group type: EXPERIMENTAL
Intervention: Surviving beyond 26 weeks
Number of subjects: 358
Study 19101496 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugenol-containing temporary cement
Number of subjects: 25
Study 19101496 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugenol-free temporary cement
Number of subjects: 25
Study 19101496 — intervention group
Group type: COMPARATOR
Intervention: Untreated teeth (negative control)
Number of subjects: 25
Study 19101496 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugenol-free cement (48-h samples)
Number of subjects: 25
Study 19101496 — intervention group
Group type: EXPERIMENTAL
Intervention: PECAM-1 reactivity
Number of subjects: 25
Study 17001223 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical training programme (30 min, 3 times a week for 3 months at 60-70% of VO2 peak)
Number of subjects: 60
Study 17001223 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical training programme
Number of subjects: 60
Study 17001223 — intervention group
Group type: COMPARATOR
Intervention: Control group (no change in previous physical activity)
Number of subjects: 60
Study 12757558 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg/d for 4 weeks and 10 mg/d per clinician's judgment thereafter)
Number of subjects: 290
Study 12757558 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 290
Study 12757558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study 10683058 — intervention group
Group type: COMPARATOR
Intervention: BVM (Bag-Valve-Mask)
Number of subjects: 830
Study 10683058 — intervention group
Group type: EXPERIMENTAL
Intervention: BVM followed by ETI (Endotracheal Intubation)
Number of subjects: 830
Study 9308762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary antioxidant vitamins for four weeks
Number of subjects: 15
Study 7955807 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg dihydroergotamine and 300 mg troxerutin three times a day
Number of subjects: 53
Study 7955807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 3675697 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 micrograms MDL 646 (alprostadil analogue)
Number of subjects: 10
Study 3675697 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 micrograms MDL 646 (alprostadil analogue)
Number of subjects: 10
Study 3675697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 28952413 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate testing phase after learning (n=30)
Number of subjects: 58
Study 28952413 — intervention group
Group type: COMPARATOR
Intervention: Delay testing phase with a 15-minute delay (n=28)
Number of subjects: 58
Study 28952413 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 28326681 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib (AZD6244, ARRY‐142886)
Number of subjects: 0
Study 28326681 — intervention group
Group type: EXPERIMENTAL
Intervention: N-desmethyl-selumetinib
Number of subjects: 0
Study 25649150 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention (Mot; risk perception and outcome expectancies) followed by self-regulatory intervention (SelfR; perceived self-efficacy and planning)
Number of subjects: 205
Study 25649150 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulatory intervention (SelfR; perceived self-efficacy and planning)
Number of subjects: 205
Study 25649150 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention (Mot; risk perception and outcome expectancies)
Number of subjects: 205
Study 25649150 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulatory module (SelfR)
Number of subjects: 205
Study 23948729 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil at night (n=54)
Number of subjects: 92
Study 23948729 — intervention group
Group type: COMPARATOR
Intervention: Galantamine in the morning (n=38)
Number of subjects: 92
Study 23948729 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil in the morning (n=24)
Number of subjects: 92
Study 23948729 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil at night (n=30)
Number of subjects: 92
Study 20684322 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g/d) and vitamin E
Number of subjects: 135
Study 20684322 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E only
Number of subjects: 135
Study 18839655 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of human placenta purified extract (PE)
Number of subjects: 79
Study 18839655 — intervention group
Group type: COMPARATOR
Intervention: Topical application of povidone iodine (PI)
Number of subjects: 79
Study 16649186 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 500 mg
Number of subjects: 465
Study 16649186 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 1000 mg
Number of subjects: 465
Study 16649186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 465
Study 16649186 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 465
Study 14657817 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg levalbuterol
Number of subjects: 482
Study 14657817 — intervention group
Group type: COMPARATOR
Intervention: 2.5 mg racemic albuterol
Number of subjects: 482
Study 10731402 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 481
Study 10731402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 481
Study 8783700 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nonabsorbable antibiotics for selective bowel decontamination (SBD)
Number of subjects: 69
Study 8783700 — intervention group
Group type: COMPARATOR
Intervention: Conventional prophylaxis with systemic antibiotics (Control)
Number of subjects: 69
Study 8783700 — intervention group
Group type: COMPARATOR
Intervention: Overall rates of bacterial and/or yeast infections
Number of subjects: 69